CUTR - Earnings announcements

CUTERA, INC. (NASDAQ:CUTR), a leading provider of aesthetic and dermatology solutions, today reported financial results for the third quarter ended September 30, 2024. Consolidated revenue for the third quarter of 2024 of $32.5 million Cash, cash equivalents, and restricted cash of $59.0 million AviClear growth of 16% vs prior year period driven by international capital system sales Global core capital growth of 7% on a sequential quarterly basis Full-year guidance maintained for both revenue and year-end cash balance "Our third quarter reflects consistent execution against our strategic priorities, with core capital sales improving on a sequential basis, AviClear continuing to

Cutera, Inc. (NASDAQ:CUTR), a leading provider of aesthetic and dermatology solutions, announced today that it will report financial results for the third quarter ended September 30, 2024, after the market closes on Thursday, November 7, 2024. The Company's management will host a conference call to discuss these results and related matters at 1:30 p.m. PT (4:30 p.m ET) that same day. Participants can register for the conference call at the following registration link. Upon registering, a calendar booking will be provided by email including the dial-in details and a unique PIN to access the call. Using this process will by-pass the operator and avoid the call queue. Registration will remai

CUTERA, INC. (NASDAQ:CUTR), a leading provider of aesthetic and dermatology solutions, today reported financial results for the second quarter ended June 30, 2024. Consolidated revenue for the second quarter of 2024 of $34.4 million Cash, cash equivalents, and restricted cash of $84.3 million AviClear growth of 41% vs prior year period driven by international capital system sales Service growth of 7% vs prior year period, highlighting improvements in field service and overall customer support Completion of the Q4 2023 corporate restructuring program, and announcement of additional cost reduction initiatives, allowing for both improved cost structure and better organization al

CUTERA, INC. (NASDAQ:CUTR), a leading provider of aesthetic and dermatology solutions, announced today that it will report financial results for the second quarter ended June 30, 2024, after the market closes on Thursday, August 8, 2024. The Company's management will host a conference call to discuss these results and related matters at 1:30 p.m. PT (4:30 p.m ET) that same day. Participants can register for the conference call by following registration link. Upon registering, a calendar booking will be provided by email including the dial-in details and a unique PIN to access the call. Using this process will by-pass the operator and avoid the call queue. Registration will remain open u

Cutera, Inc. (NASDAQ:CUTR) ("Cutera" or the "Company"), a leading provider of aesthetic and dermatology solutions, today reported financial results for the first quarter ended March 31, 2024. Consolidated revenue for the first quarter of 2024 of $38.8 million. Strong sequential increase in AviClear revenue, driven by a business model shift in North America and a successful initiation of the International limited commercial release, during the first quarter of 2024. Recent highlights include the launch of xeo+ and the inaugural session of Cutera Academy, focused on equipping customers with the tools to build successful AviClear practices. "I am pleased with our progress in the fi

Cutera, Inc. (NASDAQ:CUTR) ("Cutera" or the "Company"), a leading provider of aesthetic and dermatology solutions, today announced that it will report financial results for the first quarter ended March 31, 2024, after the market close on Thursday, May 9, 2024. The Company's management will host a conference call to discuss these results and related matters at 1:30 p.m. PT (4:30 p.m. ET) that same day. Participants can register for the conference call at the following registration link. Upon registering, a calendar booking will be provided by email including the dial-in details and a unique PIN to access the call. Using this process will by-pass the operator and avoid the call queue. Re

Cutera, Inc. (NASDAQ:CUTR) ("Cutera" or the "Company"), a leading provider of aesthetic and dermatology solutions, today reported financial results for the fourth quarter and full-year ended December 31, 2023. Consolidated revenue for the fourth quarter of 2023 of $49.5 million Full-year 2023 revenue of $212.4 million, ahead of guidance of approximately $205 million Cash and marketable securities of $143.6 million as of December 31, 2023, ahead of guidance of approximately $135 million Completion of corporate restructuring program, allowing for both an improved cost structure and better organizational alignment Successful execution of the North American limited commercial rel

Cutera, Inc. (NASDAQ:CUTR) ("Cutera" or the "Company"), a leading provider of aesthetic and dermatology solutions, today announced that it will report financial results for the fourth quarter and full year ended December 31, 2023 after the market close on Thursday, March 21, 2024. The Company intends to file its Quarterly Report on Form 10-Q for the third quarter ended September 30, 2023 and restated Quarterly Reports for the first and second quarters of 2023 in the week beginning March 4, 2024. As previously reported, the delay in filing the Quarterly Reports was due to the identification of an inventory shortfall relative to the system of record. Due to the time-consuming nature of th

Cutera, Inc. (NASDAQ:CUTR) ("Cutera" or the "Company"), a leading provider of aesthetic and dermatology solutions, today provided preliminary financial results for the third quarter ended September 30, 2023, as well as recent business updates. Some Company highlights: Consolidated revenue for the third quarter of 2023 of $46.5 million, a decrease of 26% compared to the third quarter of 2022 Cash and marketable securities of $179.5 million as of the end of the third quarter Announcement of an enhanced AviClear offering, including the option to purchase the device upfront with a corresponding reduction in treatment costs Initiation of a global restructuring program, expected to sa

Cutera, Inc. (NASDAQ:CUTR) ("Cutera" or the "Company"), a leading provider of aesthetic and dermatology solutions, today announced that it will report financial results for the third quarter of 2023 after the market close on Wednesday, November 8, 2023. The Company's management will host a conference call to discuss these results and related matters at 1:30 p.m. PT (4:30 p.m. ET) that same day. To join the conference call, dial 1-800-319-4610 (domestic) or +1-631-891-4304 (international) and ask to join Cutera's earnings conference call. The call will also be webcast and can be accessed from the Investor Relations section of Cutera's website at http://www.cutera.com/. The webcast repl

Cutera, Inc. (NASDAQ:CUTR) ("Cutera" or the "Company"), a leading provider of aesthetic and dermatology solutions, today reported financial results for the second quarter ended June 30, 2023. Second Quarter 2023 Financial and Operational Highlights Consolidated revenue of $61.2 million, a decrease of 5% as reported and a decrease of 2% in constant currency from the prior-year period, primarily driven by a decline in capital equipment revenue, partially offset by AviClear revenue. AviClear Q2 2023 new bookings of just under 200 units, vs. over 350 in Q1 2023, in line with our strategy to drive a more measured pace of new bookings. GAAP Gross margin of 45.8% in the quarter, compare

Cutera, Inc. (NASDAQ:CUTR) ("Cutera" or the "Company"), a leading provider of aesthetic and dermatology solutions, today announced that it will report financial results for the second quarter of 2023 after the market close on Tuesday, August 8, 2023. The Company's management will host a conference call to discuss these results and related matters at 1:30 p.m. PT (4:30 p.m. ET) that same day. To join the conference call, dial 1-800-319-4610 (domestic) or +1-631-891-4304 (international) and ask to join Cutera's earnings conference call. The call will also be webcast and can be accessed from the Investor Relations section of Cutera's website at http://www.cutera.com/. The webcast replay

Placed more than 350 AviClear devices during Q1 2023, and generated $4.4M in AviClear revenue in the quarter Cutera, Inc. (NASDAQ:CUTR) ("Cutera" or the "Company"), a leading provider of aesthetic and dermatology solutions, today reported financial results for the first quarter ended March 31, 2023. First Quarter 2023 Financial and Operational Highlights Consolidated revenue of $55.0 million, a decrease of 5% as reported and a decrease of 1% in constant currency from the prior-year period. During Q1 2023, the Company generated $4.4 million in AviClear revenue, consisting of treatment revenue and device license fees. AviClear placements exceeded 350 during Q1 2023, bringing cumu

Cutera, Inc. (NASDAQ:CUTR) ("Cutera" or the "Company"), a leading provider of aesthetic and dermatology solutions, today announced that it will report financial results for the first quarter of 2023 after the market close on Tuesday, May 9, 2023. The Company's management will host a conference call to discuss these results and related matters at 1:30 p.m. PT (4:30 p.m. ET) that same day. To join the conference call, dial 1-800-319-4610 (domestic) or +1-631-891-4304 (international) and ask to join Cutera's earnings conference call. The call will also be webcast and can be accessed from the Investor Relations section of Cutera's website at http://www.cutera.com/. The webcast replay of t

Highlights Former Executive Chair J. Daniel Plants' Misleading Claims and Self-Serving Agenda to Seize Control of the Company Without Paying a Control Premium and Install Himself as CEO The Special Committee of the Board of Directors (the "Special Committee") of CUTERA, INC. (the "Company") (NASDAQ:CUTR), a leading provider of aesthetic and dermatology solutions, today issued an open letter to stockholders. The full text of the letter is as follows: Dear Fellow Stockholders, We are writing to you as five independent directors on the Cutera, Inc. Board of Directors (the "Five Independent Directors")1 and as fellow stockholders of this promising company. We want to be sure you have

Full-year 2022 revenue of $252.4 million, growing 16% in constant currency Placed greater than 600 AviClear devices during 2022, and generated $4.5M in AviClear revenue in 2022 Full-year 2023 revenue outlook of $277 million to $292 million, implying 10% to 16% constant currency growth Cutera, Inc. (NASDAQ:CUTR) ("Cutera" or the "Company"), a leading provider of aesthetic and dermatology solutions, today reported financial results for the fourth quarter and full-year ended December 31, 2022. Fourth Quarter 2022 Financial and Operational Highlights Consolidated revenue of $67.4 million driven by AviClear treatment revenue and strength in Skincare, an increase of 3% as reported and 10% i

Cutera, Inc. (NASDAQ:CUTR) ("Cutera" or the "Company"), a leading provider of aesthetic and dermatology solutions, today announced that it will report financial results for the fourth quarter and full year of 2022 after the market close on Tuesday, February 28, 2023. The Company's management will host a conference call to discuss these results and related matters at 1:30 p.m. PT (4:30 p.m. ET) that same day. To join the conference call, dial 1-800-319-4610 (domestic) or +1-631-891-4304 (international) and ask to join Cutera's earnings conference call. The call will also be webcast and can be accessed from the Investor Relations section of Cutera's website at http://www.cutera.com/. The w

Cutera, Inc. (NASDAQ:CUTR) ("Cutera" or the "Company"), a leading provider of aesthetic and dermatology solutions, today announced certain preliminary, unaudited financial results for the year ended December 31, 2022. These results are subject to the completion of the Company's year-end financial reporting processes, reviews, and audit. The Company expects to report revenue in the range of $252 million to $253 million for full-year 2022, growing 15% to 16% over the prior year on a constant currency basis versus prior guidance of $255 million to $260 million. The Company plans to release full results for the fourth quarter, and fiscal year, ended December 31, 2022 after market close on F

Continued momentum in Capital equipment sales, posting 27% growth as reported and 32% in constant currency; Strong Consumable product growth reflecting robust underlying treatment volumes; Moving to full North American AviClear launch following successful limited commercial release; Reiterating full-year revenue guidance despite foreign exchange headwinds, implying year-over-year constant currency growth of approximately 20% Cutera, Inc. (NASDAQ:CUTR) ("Cutera" or the "Company"), a leading provider of aesthetic and dermatology solutions, today reported financial results for the third quarter ended September 30, 2022. Third Quarter 2022 Financial and Operational Highlights Consolidate

Cutera, Inc. (NASDAQ:CUTR) ("Cutera" or the "Company"), a leading provider of aesthetic and dermatology solutions, today announced that it will report financial results for the third quarter of 2022 after the market close on Thursday, November 3, 2022. The Company's management will host a conference call to discuss these results and related matters at 1:30 p.m. PT (4:30 p.m. ET) that same day. To join the conference call, dial 1-800-319-4610 (domestic) or +1-631-891-4304 (international) and ask to join Cutera's earnings conference call. The call will also be webcast and can be accessed from the Investor Relations section of Cutera's website at http://www.cutera.com/. The webcast replay o

Record second-quarter revenue driven by ongoing momentum in Capital Equipment and Consumable Product segments Over one hundred new patients treated during the first quarter of AviClear's availability Management reiterates full-year revenue guidance despite $15 million of annual foreign exchange headwinds Cutera, Inc. (NASDAQ:CUTR) ("Cutera" or the "Company"), a leading provider of aesthetic and dermatology solutions, today reported financial results for the second quarter ended June 30, 2022. Second Quarter 2022 Financial and Operational Highlights Consolidated revenue of $64.2 million driven by strength in capital equipment and consumable product demand. Over 50 AviClear devices we

Cutera, Inc. (NASDAQ:CUTR) ("Cutera" or the "Company"), a leading provider of aesthetic and dermatology solutions, today announced that it will report financial results for the second quarter after the market close on Thursday, August 4, 2022. The Company's management will host a conference call to discuss these results and related matters at 1:15 p.m. PT (4:15 p.m. ET) that same day. To join the conference call, dial 1-800-319-4610 (domestic) or +1-631-891-4304 (international). The call will also be webcast and can be accessed from the Investor Relations section of Cutera's website at http://www.cutera.com/. The webcast replay of the call will be available at the same site approximately

Delivers 17% revenue growth as reported and 21% on a constant currency basis AviClear™ investments were accelerated in 1Q22 ahead of FDA device clearance New ERP system launched Company reiterates full-year guidance at current exchange rates Cutera, Inc. (NASDAQ:CUTR) ("Cutera" or the "Company"), a leading provider of aesthetic and dermatology solutions, today reported financial results for the first quarter ended March 31, 2022. First Quarter 2022 Financial and Operational Highlights Revenue was $58.0 million, an increase of 17% from the prior-year period as reported and 21% on a constant currency basis, driven by robust performance across the business, with particular strength in N

Cutera, Inc. (NASDAQ:CUTR) ("Cutera" or the "Company"), a leading provider of aesthetic and dermatology solutions, today announced that it will report financial results for the first quarter of 2022 after the market close on Tuesday, May 10, 2022. The Company's management will host a conference call to discuss these results and related matters at 1:30 p.m. PT (4:30 p.m. ET) that same day. To join the conference call, dial 1-800-381-7839 (domestic) or +1-416-981-0157 (international) and refer to the Conference ID: 22017471. The call will be webcast live and be available for access one hour after the end of the call from the Investor Relations section of Cutera's website at http://www.cute

Cutera, Inc. (NASDAQ:CUTR) ("Cutera" or the "Company"), a leading provider of laser and energy-based aesthetic systems for practitioners worldwide, today announced that it will report financial results for the fourth quarter and full year 2021 after the market close on Tuesday, February 22, 2022. The Company's management will host a conference call to discuss these results and related matters at 1:30 p.m. PT (4:30 p.m. ET) that same day. To join the conference call, dial 1-877-705-6003 (domestic) or +1-201-493-6725 (international) and refer to the Conference ID: 13726648. The call will also be webcast and can be accessed from the Investor Relations section of Cutera's website at http://w

Cutera, Inc. (NASDAQ:CUTR) ("Cutera" or the "Company"), a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide, today reported financial results for the third quarter ended September 30, 2021. Third Quarter 2021 Financial and Operational Highlights Revenue was $57.4 million, an increase of 47% from the prior-year period, driven by strong performance across the business, with strength occurring in capital equipment and recurring revenue. Capital Equipment revenue of $32.2 million increased 33% over the prior-year period. Recurring revenue, defined as the combination of Skincare, Consumable Products, and Service, was $25.2 million, an increase

Cutera, Inc. (NASDAQ:CUTR) ("Cutera" or the "Company"), a leading provider of laser and energy-based aesthetic systems for practitioners worldwide, today announced that it will report financial results for the third quarter of 2021 after the market close on Wednesday, November 3, 2021. The Company's management will host a conference call to discuss these results and related matters at 1:30 p.m. PT (4:30 p.m. ET) that same day. To join the conference call, dial 1-877-705-6003 (domestic) or + 1-201-493-6725 (international) and refer to the Conference ID: 13723851. The call will also be webcast and can be accessed from the "Investors" section of Cutera's website at http://www.cutera.com/. T

Cutera, Inc. (NASDAQ:CUTR) ("Cutera" or the "Company"), a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide, today reported financial results for the second quarter ended June 30, 2021. Second Quarter 2021 Financial and Operational Highlights Revenue was $58.6 million, an increase of 122% from the prior-year period, driven by robust performance across the business, with strength in both capital equipment and recurring revenue segments. Capital Equipment revenue of $35.6 million increased 129% over the prior-year period. Recurring revenue was $23.0 million, an increase of 113% over the prior-year period: Skin Care revenue of $11.8 million